T1	B-Protein	0	3	ERP	ERP	B-NP	NN	B-protein	5	NMOD	B-protein
O	O	3	4	,	,	O	,	O	5	P	O
O	O	5	6	a	a	B-NP	DT	O	5	NMOD	O
O	O	7	10	new	new	I-NP	JJ	O	5	NMOD	O
O	O	11	17	member	member	I-NP	NN	O	21	NMOD	O
O	O	18	20	of	of	B-PP	IN	O	5	NMOD	O
O	O	21	24	the	the	B-NP	DT	O	13	NMOD	O
O	O	25	28	ets	ets	I-NP	NN	B-protein	13	NMOD	B-protein
O	O	29	42	transcription	transcription	I-NP	NN	I-protein	13	NMOD	I-protein
O	O	43	49	factor	factor	I-NP	NN	I-protein	13	NMOD	I-protein
O	O	49	50	/	/	B-NP	SYM	O	13	P	O
O	O	50	61	oncoprotein	oncoprotein	I-NP	NN	B-protein	13	NMOD	B-protein
O	O	62	68	family	family	I-NP	NN	I-protein	6	PMOD	I-protein
O	O	68	69	:	:	O	:	O	5	P	O
O	O	70	77	cloning	cloning	B-NP	NN	O	21	NMOD	O
O	O	77	78	,	,	O	,	O	21	P	O
O	O	79	95	characterization	characterization	B-NP	NN	O	21	NMOD	O
O	O	95	96	,	,	O	,	O	21	P	O
O	O	97	100	and	and	O	CC	O	21	NMOD	O
O	O	101	113	differential	differential	B-NP	JJ	O	21	NMOD	O
O	O	114	124	expression	expression	I-NP	NN	O	0	ROOT	O
O	O	125	131	during	during	B-PP	IN	O	21	NMOD	O
O	O	132	133	B	B	B-NP	NN	O	26	NMOD	O
O	O	133	134	-	-	B-NP	HYPH	O	26	NMOD	O
O	O	134	144	lymphocyte	lymphocyte	I-NP	NN	O	26	NMOD	O
O	O	145	156	development	development	I-NP	NN	O	22	PMOD	O
O	O	156	157	.	.	O	.	O	21	P	O

O	O	159	162	The	The	B-NP	DT	O	4	NMOD	O
T14	B-Entity	163	166	ets	ets	I-NP	NN	B-DNA	4	NMOD	B-DNA
T14	I-Entity	167	171	gene	gene	I-NP	NN	I-DNA	4	NMOD	I-DNA
T14	I-Entity	172	178	family	family	I-NP	NN	I-DNA	5	SUB	I-DNA
O	O	179	186	encodes	encode	B-VP	VBZ	O	0	ROOT	O
O	O	187	188	a	a	B-NP	DT	O	7	NMOD	O
O	O	189	194	group	group	I-NP	NN	O	5	OBJ	O
O	O	195	197	of	of	B-PP	IN	O	7	NMOD	O
O	O	198	206	proteins	protein	B-NP	NNS	O	8	PMOD	O
O	O	207	212	which	which	B-NP	WDT	O	9	NMOD	O
O	O	213	221	function	function	B-VP	VBP	O	10	SBAR	O
O	O	222	224	as	as	B-PP	IN	O	11	VMOD	O
O	O	225	238	transcription	transcription	B-NP	NN	B-protein	14	NMOD	B-protein
O	O	239	246	factors	factor	I-NP	NNS	I-protein	12	PMOD	I-protein
O	O	247	252	under	under	B-PP	IN	O	11	VMOD	O
O	O	253	266	physiological	physiological	B-NP	JJ	O	17	NMOD	O
O	O	267	277	conditions	condition	I-NP	NNS	O	15	PMOD	O
O	O	278	281	and	and	O	CC	O	11	VMOD	O
O	O	281	282	,	,	O	,	O	11	P	O
O	O	283	285	if	if	B-SBAR	IN	O	11	VMOD	O
O	O	286	296	aberrantly	aberrantly	B-ADVP	RB	O	20	DEP	O
O	O	297	306	expressed	express	B-VP	VBN	O	20	DEP	O
O	O	306	307	,	,	O	,	O	11	P	O
O	O	308	311	can	can	B-VP	MD	O	11	VMOD	O
O	O	312	317	cause	cause	I-VP	VB	O	24	VC	O
O	O	318	326	cellular	cellular	B-NP	JJ	O	27	NMOD	O
O	O	327	341	transformation	transformation	I-NP	NN	O	25	OBJ	O
O	O	341	342	.	.	O	.	O	5	P	O

O	O	343	345	We	We	B-NP	PRP	O	2	SUB	O
O	O	346	350	have	have	B-VP	VBP	O	0	ROOT	O
O	O	351	359	recently	recently	I-VP	RB	O	2	VMOD	O
O	O	360	370	identified	identify	I-VP	VBN	O	2	VC	O
O	O	371	374	two	two	B-NP	CD	O	7	NMOD	O
O	O	375	385	regulatory	regulatory	I-NP	JJ	B-DNA	7	NMOD	B-DNA
O	O	386	394	elements	element	I-NP	NNS	I-DNA	4	OBJ	I-DNA
O	O	395	397	in	in	B-PP	IN	O	7	NMOD	O
O	O	398	401	the	the	B-NP	DT	O	22	NMOD	O
T15	B-Entity	402	408	murine	murine	I-NP	JJ	B-DNA	22	NMOD	B-DNA
T15	I-Entity	409	423	immunoglobulin	immunoglobulin	I-NP	NN	I-DNA	22	NMOD	I-DNA
T15	I-Entity	424	429	heavy	heavy	B-ADJP	JJ	I-DNA	22	NMOD	I-DNA
T15	I-Entity	429	430	-	-	O	HYPH	I-DNA	22	NMOD	I-DNA
T15	I-Entity	430	435	chain	chain	B-NP	NN	I-DNA	18	NMOD	I-DNA
T15	I-Entity	436	437	(	(	O	(	I-DNA	18	NMOD	I-DNA
T15	I-Entity	437	440	IgH	IgH	B-NP	NN	I-DNA	18	NMOD	I-DNA
T15	I-Entity	440	441	)	)	O	)	I-DNA	18	NMOD	I-DNA
T15	I-Entity	442	450	enhancer	enhancer	B-NP	NN	I-DNA	22	NMOD	I-DNA
O	O	450	451	,	,	O	,	O	22	P	O
T16	B-Entity	452	454	pi	pi	B-NP	NN	B-DNA	22	NMOD	B-DNA
O	O	455	458	and	and	I-NP	CC	O	22	NMOD	O
T17	B-Entity	459	465	microB	microB	I-NP	NN	B-DNA	8	PMOD	B-DNA
O	O	465	466	,	,	O	,	O	22	P	O
O	O	467	472	which	which	B-NP	WDT	O	22	NMOD	O
O	O	473	480	exhibit	exhibit	B-VP	VBP	O	24	SBAR	O
O	O	481	489	striking	striking	B-NP	JJ	O	27	NMOD	O
O	O	490	500	similarity	similarity	I-NP	NN	O	25	OBJ	O
O	O	501	503	to	to	B-PP	TO	O	27	NMOD	O
T18	B-Entity	504	511	binding	bind	B-NP	VBG	B-DNA	30	NMOD	B-DNA
T18	I-Entity	512	517	sites	site	I-NP	NNS	I-DNA	28	PMOD	I-DNA
O	O	518	521	for	for	B-PP	IN	O	30	NMOD	O
O	O	522	525	ets	ets	B-NP	NN	B-protein	35	NMOD	B-protein
O	O	525	526	-	-	B-NP	HYPH	I-protein	35	NMOD	I-protein
O	O	526	533	related	relate	I-NP	VBN	I-protein	35	NMOD	I-protein
O	O	534	542	proteins	protein	I-NP	NNS	I-protein	31	PMOD	I-protein
O	O	542	543	.	.	O	.	O	2	P	O

O	O	544	546	To	To	B-VP	TO	O	2	VMOD	O
O	O	547	555	identify	identify	I-VP	VB	O	27	VMOD	O
O	O	556	559	ets	ets	B-NP	NN	B-protein	5	AMOD	B-protein
O	O	559	560	-	-	O	HYPH	O	3	P	O
O	O	560	567	related	relate	B-VP	VBN	O	7	NMOD	O
O	O	568	583	transcriptional	transcriptional	B-NP	JJ	B-protein	7	NMOD	B-protein
O	O	584	594	regulators	regulator	I-NP	NNS	I-protein	2	OBJ	I-protein
O	O	595	604	expressed	express	B-VP	VBN	O	7	NMOD	O
O	O	605	607	in	in	B-PP	IN	O	8	VMOD	O
O	O	608	611	pre	pre	B-NP	AFX	B-DNA	13	NMOD	B-DNA
O	O	611	612	-	-	I-NP	HYPH	O	13	P	O
O	O	612	613	B	B	I-NP	NN	B-cell_type	13	NMOD	B-cell_type
O	O	614	625	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	9	PMOD	I-cell_type
O	O	626	630	that	that	B-NP	WDT	O	13	NMOD	O
O	O	631	634	may	may	B-VP	MD	O	14	SBAR	O
O	O	635	643	interact	interact	I-VP	VB	O	15	VC	O
O	O	644	648	with	with	B-PP	IN	O	16	VMOD	O
O	O	649	655	either	either	O	CC	O	24	NMOD	O
O	O	656	659	the	the	B-NP	DT	O	20	NMOD	O
O	O	660	662	pi	pi	I-NP	NN	B-DNA	24	NMOD	B-DNA
O	O	663	665	or	or	O	CC	O	24	NMOD	O
O	O	666	669	the	the	B-NP	DT	O	24	NMOD	O
O	O	670	676	microB	microB	I-NP	NN	B-DNA	24	NMOD	B-DNA
T19	B-Entity	677	681	site	site	I-NP	NN	I-DNA	17	PMOD	I-DNA
O	O	681	682	,	,	O	,	O	27	P	O
O	O	683	685	we	we	B-NP	PRP	O	27	SUB	O
O	O	686	690	have	have	B-VP	VBP	O	0	ROOT	O
O	O	691	695	used	use	I-VP	VBN	O	27	VC	O
O	O	696	697	a	a	B-NP	DT	O	31	NMOD	O
O	O	698	701	PCR	PCR	I-NP	NN	O	31	NMOD	O
O	O	702	710	approach	approach	I-NP	NN	O	28	OBJ	O
O	O	711	715	with	with	B-PP	IN	O	31	NMOD	O
T20	B-Entity	716	726	degenerate	degenerate	B-NP	JJ	O	34	NMOD	O
T20	I-Entity	727	743	oligonucleotides	oligonucleotide	I-NP	NNS	O	32	PMOD	O
O	O	744	752	encoding	encode	B-VP	VBG	O	34	NMOD	O
O	O	753	762	conserved	conserve	B-NP	VBN	O	37	NMOD	O
O	O	763	772	sequences	sequence	I-NP	NNS	O	35	OBJ	O
O	O	773	775	in	in	B-PP	IN	O	35	VMOD	O
O	O	776	779	all	all	B-NP	DT	O	40	NMOD	O
O	O	780	787	members	member	I-NP	NNS	O	38	PMOD	O
O	O	788	790	of	of	B-PP	IN	O	40	NMOD	O
O	O	791	794	the	the	B-NP	DT	O	44	NMOD	O
O	O	795	798	ets	ets	I-NP	NN	B-protein	44	NMOD	B-protein
O	O	799	805	family	family	I-NP	NN	I-protein	41	PMOD	I-protein
O	O	805	806	.	.	O	.	O	27	P	O

O	O	807	809	We	We	B-NP	PRP	O	2	SUB	O
O	O	810	814	have	have	B-VP	VBP	O	0	ROOT	O
O	O	815	821	cloned	clone	I-VP	VBN	O	2	VC	O
O	O	822	825	the	the	B-NP	DT	O	5	NMOD	O
O	O	826	830	gene	gene	I-NP	NN	O	3	OBJ	O
O	O	831	834	for	for	B-PP	IN	O	3	VMOD	O
O	O	835	836	a	a	B-NP	DT	O	9	NMOD	O
O	O	837	840	new	new	I-NP	JJ	O	9	NMOD	O
O	O	841	844	ets	ets	I-NP	NN	O	13	NMOD	O
O	O	844	845	-	-	B-VP	HYPH	O	13	NMOD	O
O	O	845	852	related	relate	B-NP	VBN	O	13	NMOD	O
O	O	853	866	transcription	transcription	I-NP	NN	B-protein	13	NMOD	B-protein
O	O	867	873	factor	factor	I-NP	NN	I-protein	15	NMOD	I-protein
O	O	873	874	,	,	O	,	O	15	P	O
T2	B-Protein	875	878	ERP	ERP	B-NP	NN	B-protein	6	PMOD	B-protein
O	O	879	880	(	(	O	(	O	21	DEP	O
T3	B-Protein	880	883	ets	ets	B-NP	NN	B-protein	20	NMOD	B-protein
T3	I-Protein	883	884	-	-	O	HYPH	I-protein	20	NMOD	I-protein
T3	I-Protein	884	891	related	relate	B-NP	VBN	I-protein	20	NMOD	I-protein
T3	I-Protein	892	899	protein	protein	I-NP	NN	I-protein	21	DEP	I-protein
O	O	899	900	)	)	O	)	O	15	NMOD	O
O	O	900	901	,	,	O	,	O	3	P	O
O	O	902	906	from	from	B-PP	IN	O	3	VMOD	O
O	O	907	910	the	the	B-NP	DT	O	32	NMOD	O
O	O	911	917	murine	murine	I-NP	JJ	B-cell_line	30	NMOD	B-cell_line
O	O	918	921	pre	pre	I-NP	AFX	I-cell_line	30	NMOD	I-cell_line
O	O	921	922	-	-	I-NP	HYPH	I-cell_line	30	NMOD	I-cell_line
O	O	922	923	B	B	I-NP	NN	I-cell_line	30	NMOD	I-cell_line
O	O	924	928	cell	cell	I-NP	NN	I-cell_line	30	NMOD	I-cell_line
O	O	929	933	line	line	I-NP	NN	I-cell_line	32	NMOD	I-cell_line
O	O	934	938	BASC	BASC	I-NP	NN	B-cell_line	32	NMOD	B-cell_line
O	O	939	942	6C2	6C2	I-NP	NN	I-cell_line	23	PMOD	I-cell_line
O	O	943	946	and	and	B-PP	CC	O	23	PMOD	O
O	O	947	951	from	from	B-PP	IN	O	23	PMOD	O
O	O	952	957	mouse	mouse	B-NP	NN	O	37	NMOD	O
O	O	958	962	lung	lung	I-NP	NN	O	37	NMOD	O
O	O	963	969	tissue	tissue	I-NP	NN	O	34	PMOD	O
O	O	969	970	.	.	O	.	O	2	P	O

O	O	971	974	The	The	B-NP	DT	O	3	NMOD	O
T4	B-Protein	975	978	ERP	ERP	I-NP	NN	B-protein	3	NMOD	B-protein
O	O	979	986	protein	protein	I-NP	NN	I-protein	4	SUB	I-protein
O	O	987	995	contains	contain	B-VP	VBZ	O	0	ROOT	O
O	O	996	997	a	a	B-NP	DT	O	6	NMOD	O
O	O	998	1004	region	region	I-NP	NN	O	16	NMOD	O
O	O	1005	1007	of	of	B-PP	IN	O	6	NMOD	O
O	O	1008	1012	high	high	B-NP	JJ	O	9	NMOD	O
O	O	1013	1021	homology	homology	I-NP	NN	O	7	PMOD	O
O	O	1022	1026	with	with	B-PP	IN	O	6	NMOD	O
O	O	1027	1030	the	the	B-NP	DT	O	13	NMOD	O
T21	B-Entity	1031	1034	ETS	ETS	I-NP	NN	B-DNA	13	NMOD	B-DNA
T21	I-Entity	1035	1038	DNA	DNA	I-NP	NN	I-DNA	10	PMOD	I-DNA
T21	I-Entity	1038	1039	-	-	O	HYPH	O	6	P	O
T21	I-Entity	1039	1046	binding	bind	B-NP	VBG	O	16	NMOD	O
T21	I-Entity	1047	1053	domain	domain	I-NP	NN	O	4	OBJ	O
O	O	1054	1060	common	common	B-ADJP	JJ	O	16	NMOD	O
O	O	1061	1063	to	to	B-PP	TO	O	17	AMOD	O
O	O	1064	1067	all	all	B-NP	DT	O	20	NMOD	O
O	O	1068	1075	members	member	I-NP	NNS	O	18	PMOD	O
O	O	1076	1078	of	of	B-PP	IN	O	20	NMOD	O
O	O	1079	1082	the	the	B-NP	DT	O	28	NMOD	O
O	O	1083	1086	ets	ets	I-NP	NN	B-protein	28	NMOD	B-protein
O	O	1087	1100	transcription	transcription	I-NP	NN	I-protein	28	NMOD	I-protein
O	O	1101	1107	factor	factor	I-NP	NN	I-protein	28	NMOD	I-protein
O	O	1107	1108	/	/	B-NP	SYM	O	28	P	O
O	O	1108	1119	oncoprotein	oncoprotein	I-NP	NN	B-protein	28	NMOD	B-protein
O	O	1120	1126	family	family	I-NP	NN	I-protein	21	PMOD	I-protein
O	O	1126	1127	.	.	O	.	O	4	P	O

O	O	1128	1133	Three	Three	B-NP	CD	O	4	NMOD	O
O	O	1134	1144	additional	additional	I-NP	JJ	O	3	AMOD	O
O	O	1145	1152	smaller	small	I-NP	JJR	O	4	NMOD	O
O	O	1153	1160	regions	region	I-NP	NNS	O	5	SUB	O
O	O	1161	1165	show	show	B-VP	VBP	O	0	ROOT	O
O	O	1166	1174	homology	homology	B-NP	NN	O	5	OBJ	O
O	O	1175	1177	to	to	B-PP	TO	O	6	NMOD	O
O	O	1178	1181	the	the	B-NP	DT	O	16	NMOD	O
T5	B-Protein	1182	1185	ELK	ELK	I-NP	NN	B-protein	16	NMOD	B-protein
T5	I-Protein	1185	1186	-	-	B-NP	HYPH	O	16	P	O
T5	I-Protein	1186	1187	1	1	I-NP	CD	O	16	NMOD	O
O	O	1188	1191	and	and	I-NP	CC	O	13	NMOD	O
T6	B-Protein	1192	1195	SAP	SAP	I-NP	NN	B-protein	16	NMOD	B-protein
T6	I-Protein	1195	1196	-	-	B-NP	HYPH	O	16	NMOD	O
T6	I-Protein	1196	1197	1	1	I-NP	CD	B-DNA	16	NMOD	B-DNA
O	O	1198	1203	genes	gene	I-NP	NNS	I-DNA	19	NMOD	I-DNA
O	O	1203	1204	,	,	O	,	O	19	P	O
O	O	1205	1206	a	a	B-NP	DT	O	19	NMOD	O
O	O	1207	1215	subgroup	subgroup	I-NP	NN	O	7	PMOD	O
O	O	1216	1218	of	of	B-PP	IN	O	19	NMOD	O
O	O	1219	1222	the	the	B-NP	DT	O	24	NMOD	O
T22	B-Entity	1223	1226	ets	ets	I-NP	NN	B-DNA	24	NMOD	B-DNA
T22	I-Entity	1227	1231	gene	gene	I-NP	NN	I-DNA	24	NMOD	I-DNA
T22	I-Entity	1232	1238	family	family	I-NP	NN	I-DNA	20	PMOD	I-DNA
O	O	1239	1243	that	that	B-NP	WDT	O	24	NMOD	O
O	O	1244	1253	interacts	interact	B-VP	VBZ	O	25	SBAR	O
O	O	1254	1258	with	with	B-PP	IN	O	26	VMOD	O
O	O	1259	1262	the	the	B-NP	DT	O	31	NMOD	O
T7	B-Protein	1263	1268	serum	serum	I-NP	NN	B-protein	31	NMOD	B-protein
T7	I-Protein	1269	1277	response	response	I-NP	NN	I-protein	31	NMOD	I-protein
T7	I-Protein	1278	1284	factor	factor	I-NP	NN	I-protein	27	PMOD	I-protein
O	O	1284	1285	.	.	O	.	O	5	P	O

O	O	1286	1290	Full	Full	B-NP	JJ	O	4	NMOD	O
O	O	1290	1291	-	-	I-NP	HYPH	O	4	NMOD	O
O	O	1291	1297	length	length	I-NP	NN	O	4	NMOD	O
T8	B-Protein	1298	1301	ERP	ERP	I-NP	NN	B-protein	5	SUB	B-protein
O	O	1302	1311	expresses	express	B-VP	VBZ	O	0	ROOT	O
O	O	1312	1316	only	only	B-NP	RB	O	11	NMOD	O
O	O	1317	1327	negligible	negligible	I-NP	JJ	B-DNA	8	NMOD	B-DNA
O	O	1328	1331	DNA	DNA	I-NP	NN	I-DNA	11	NMOD	I-DNA
O	O	1331	1332	-	-	B-NP	HYPH	O	11	NMOD	O
O	O	1332	1339	binding	binding	I-NP	NN	O	11	NMOD	O
O	O	1340	1348	activity	activity	I-NP	NN	O	5	OBJ	O
O	O	1349	1351	by	by	B-PP	IN	O	5	VMOD	O
O	O	1352	1358	itself	itself	B-NP	PRP	O	12	PMOD	O
O	O	1358	1359	.	.	O	.	O	5	P	O

O	O	1360	1367	Removal	Removal	B-NP	NN	O	6	SUB	O
O	O	1368	1370	of	of	B-PP	IN	O	1	NMOD	O
O	O	1371	1374	the	the	B-NP	DT	O	5	NMOD	O
T23	B-Entity	1375	1382	carboxy	carboxy	I-NP	NN	B-protein	5	NMOD	B-protein
T23	I-Entity	1383	1391	terminus	terminus	I-NP	NN	I-protein	2	PMOD	I-protein
O	O	1392	1399	enables	enable	B-VP	VBZ	O	0	ROOT	O
T9	B-Protein	1400	1403	ERP	ERP	B-NP	NN	B-protein	9	SUB	B-protein
O	O	1404	1406	to	to	B-VP	TO	O	9	VMOD	O
O	O	1407	1415	interact	interact	I-VP	VB	O	6	VMOD	O
O	O	1416	1420	with	with	B-PP	IN	O	9	VMOD	O
O	O	1421	1422	a	a	B-NP	DT	O	12	NMOD	O
O	O	1423	1430	variety	variety	I-NP	NN	O	10	PMOD	O
O	O	1431	1433	of	of	B-PP	IN	O	12	NMOD	O
T24	B-Entity	1434	1437	ets	ets	B-NP	NN	B-DNA	17	NMOD	B-DNA
T24	I-Entity	1437	1438	-	-	O	HYPH	I-DNA	14	P	I-DNA
T24	I-Entity	1438	1445	binding	bind	B-VP	VBG	I-DNA	17	NMOD	I-DNA
T24	I-Entity	1446	1451	sites	site	B-NP	NNS	I-DNA	13	PMOD	I-DNA
O	O	1452	1461	including	include	B-PP	VBG	O	17	NMOD	O
O	O	1462	1465	the	the	B-NP	DT	O	21	NMOD	O
T25	B-Entity	1466	1469	E74	E74	I-NP	NN	B-DNA	21	NMOD	B-DNA
T25	I-Entity	1470	1474	site	site	I-NP	NN	I-DNA	34	NMOD	I-DNA
O	O	1474	1475	,	,	O	,	O	34	P	O
O	O	1476	1479	the	the	B-NP	DT	O	27	NMOD	O
T26	B-Entity	1480	1483	IgH	IgH	I-NP	NN	B-DNA	27	NMOD	B-DNA
T26	I-Entity	1484	1492	enhancer	enhancer	I-NP	NN	I-DNA	27	NMOD	I-DNA
T26	I-Entity	1493	1495	pi	pi	I-NP	NN	I-DNA	27	NMOD	I-DNA
T26	I-Entity	1496	1500	site	site	I-NP	NN	I-DNA	34	NMOD	I-DNA
O	O	1500	1501	,	,	O	,	O	34	P	O
O	O	1502	1505	and	and	O	CC	O	34	NMOD	O
O	O	1506	1509	the	the	B-NP	DT	O	34	NMOD	O
T10	B-Protein	1510	1513	lck	lck	I-NP	NN	B-DNA	34	NMOD	B-DNA
T27	B-Entity	1514	1522	promoter	promoter	I-NP	NN	I-DNA	34	NMOD	I-DNA
T27	I-Entity	1523	1526	ets	ets	I-NP	NN	I-DNA	34	NMOD	I-DNA
T27	I-Entity	1527	1531	site	site	I-NP	NN	I-DNA	18	PMOD	I-DNA
O	O	1531	1532	,	,	O	,	O	6	P	O
O	O	1533	1543	suggesting	suggest	B-VP	VBG	O	6	VMOD	O
O	O	1544	1545	a	a	B-NP	DT	O	43	NMOD	O
T28	B-Entity	1546	1553	carboxy	carboxy	I-NP	NN	B-protein	43	NMOD	B-protein
T28	I-Entity	1553	1554	-	-	B-NP	HYPH	I-protein	43	NMOD	I-protein
T28	I-Entity	1554	1562	terminal	terminal	I-NP	JJ	I-protein	43	NMOD	I-protein
T28	I-Entity	1563	1571	negative	negative	I-NP	JJ	I-protein	43	NMOD	I-protein
T28	I-Entity	1572	1582	regulatory	regulatory	I-NP	JJ	I-protein	43	NMOD	I-protein
T28	I-Entity	1583	1589	domain	domain	I-NP	NN	I-protein	36	OBJ	I-protein
O	O	1589	1590	.	.	O	.	O	6	P	O

O	O	1591	1593	At	At	B-NP	IN	O	7	NMOD	O
O	O	1594	1599	least	least	I-NP	JJS	O	1	AMOD	O
O	O	1600	1605	three	three	I-NP	CD	O	1	AMOD	O
T11	B-Protein	1606	1609	ERP	ERP	I-NP	NN	B-protein	7	NMOD	B-protein
O	O	1609	1610	-	-	B-NP	HYPH	O	7	NMOD	O
O	O	1610	1617	related	relate	I-NP	VBN	O	7	NMOD	O
O	O	1618	1629	transcripts	transcript	I-NP	NNS	O	8	SUB	O
O	O	1630	1633	are	be	B-VP	VBP	O	0	ROOT	O
O	O	1634	1643	expressed	express	I-VP	VBN	O	8	VC	O
O	O	1644	1646	in	in	B-PP	IN	O	9	VMOD	O
O	O	1647	1648	a	a	B-NP	DT	O	12	NMOD	O
O	O	1649	1656	variety	variety	I-NP	NN	O	10	PMOD	O
O	O	1657	1659	of	of	B-PP	IN	O	12	NMOD	O
O	O	1660	1667	tissues	tissue	B-NP	NNS	O	13	PMOD	O
O	O	1667	1668	.	.	O	.	O	8	P	O

O	O	1669	1676	However	However	B-ADVP	RB	O	11	VMOD	O
O	O	1676	1677	,	,	O	,	O	11	P	O
O	O	1678	1684	within	within	B-PP	IN	O	11	VMOD	O
O	O	1685	1688	the	the	B-NP	DT	O	8	NMOD	O
O	O	1689	1690	B	B	I-NP	NN	B-cell_type	8	NMOD	B-cell_type
O	O	1690	1691	-	-	B-NP	HYPH	I-cell_type	8	NMOD	I-cell_type
O	O	1691	1695	cell	cell	I-NP	NN	I-cell_type	8	NMOD	I-cell_type
O	O	1696	1703	lineage	lineage	I-NP	NN	I-cell_type	3	PMOD	I-cell_type
O	O	1703	1704	,	,	O	,	O	11	P	O
T12	B-Protein	1705	1708	ERP	ERP	B-NP	NN	B-protein	11	SUB	B-protein
O	O	1709	1711	is	be	B-VP	VBZ	O	34	VMOD	O
O	O	1712	1718	highly	highly	I-VP	RB	O	11	VMOD	O
O	O	1719	1728	expressed	express	I-VP	VBN	O	11	VC	O
O	O	1729	1738	primarily	primarily	B-ADVP	RB	O	13	VMOD	O
O	O	1739	1741	at	at	B-PP	IN	O	13	VMOD	O
O	O	1742	1747	early	early	B-NP	JJ	O	17	NMOD	O
O	O	1748	1754	stages	stage	I-NP	NNS	O	15	PMOD	O
O	O	1755	1757	of	of	B-PP	IN	O	17	NMOD	O
O	O	1758	1759	B	B	B-NP	NN	B-cell_type	22	NMOD	B-cell_type
O	O	1759	1760	-	-	B-NP	HYPH	I-cell_type	22	NMOD	I-cell_type
O	O	1760	1770	lymphocyte	lymphocyte	I-NP	NN	I-cell_type	22	NMOD	I-cell_type
O	O	1771	1782	development	development	I-NP	NN	O	18	PMOD	O
O	O	1782	1783	,	,	O	,	O	34	P	O
O	O	1784	1787	and	and	O	CC	O	34	VMOD	O
O	O	1788	1798	expression	expression	B-NP	NN	O	26	SUB	O
O	O	1799	1807	declines	decline	B-VP	VBZ	O	34	VMOD	O
O	O	1808	1819	drastically	drastically	B-ADVP	RB	O	26	VMOD	O
O	O	1820	1824	upon	upon	B-PP	IN	O	26	VMOD	O
O	O	1825	1826	B	B	B-NP	NN	O	32	NMOD	O
O	O	1826	1827	-	-	B-NP	HYPH	O	32	NMOD	O
O	O	1827	1831	cell	cell	I-NP	NN	O	32	NMOD	O
O	O	1832	1842	maturation	maturation	I-NP	NN	O	28	PMOD	O
O	O	1842	1843	,	,	O	,	O	34	P	O
O	O	1844	1855	correlating	correlate	B-VP	VBG	O	0	ROOT	O
O	O	1856	1860	with	with	B-PP	IN	O	34	VMOD	O
O	O	1861	1864	the	the	B-NP	DT	O	38	NMOD	O
O	O	1865	1873	enhancer	enhancer	I-NP	NN	O	38	NMOD	O
O	O	1874	1882	activity	activity	I-NP	NN	O	35	PMOD	O
O	O	1883	1885	of	of	B-PP	IN	O	38	NMOD	O
O	O	1886	1889	the	the	B-NP	DT	O	43	NMOD	O
T29	B-Entity	1890	1893	IgH	IgH	I-NP	NN	B-DNA	43	NMOD	B-DNA
T29	I-Entity	1894	1896	pi	pi	I-NP	NN	I-DNA	43	NMOD	I-DNA
T29	I-Entity	1897	1901	site	site	I-NP	NN	I-DNA	39	PMOD	I-DNA
O	O	1901	1902	.	.	O	.	O	34	P	O

O	O	1903	1908	These	These	B-NP	DT	O	2	NMOD	O
O	O	1909	1913	data	datum	I-NP	NNS	O	3	SUB	O
O	O	1914	1921	suggest	suggest	B-VP	VBP	O	0	ROOT	O
O	O	1922	1926	that	that	B-SBAR	IN	O	3	VMOD	O
T13	B-Protein	1927	1930	ERP	ERP	B-NP	NN	B-protein	6	SUB	B-protein
O	O	1931	1936	might	might	B-VP	MD	O	4	SBAR	O
O	O	1937	1941	play	play	I-VP	VB	O	6	VC	O
O	O	1942	1943	a	a	B-NP	DT	O	9	NMOD	O
O	O	1944	1948	role	role	I-NP	NN	O	7	OBJ	O
O	O	1949	1951	in	in	B-PP	IN	O	7	VMOD	O
O	O	1952	1953	B	B	B-NP	NN	O	14	NMOD	O
O	O	1953	1954	-	-	B-NP	HYPH	O	14	NMOD	O
O	O	1954	1958	cell	cell	I-NP	NN	O	14	NMOD	O
O	O	1959	1970	development	development	I-NP	NN	O	10	PMOD	O
O	O	1971	1974	and	and	B-PP	CC	O	10	PMOD	O
O	O	1975	1977	in	in	B-PP	IN	O	10	PMOD	O
T30	B-Entity	1978	1981	IgH	IgH	B-NP	NN	B-DNA	18	NMOD	B-DNA
T30	I-Entity	1982	1986	gene	gene	I-NP	NN	I-DNA	19	NMOD	I-DNA
O	O	1987	1997	regulation	regulation	I-NP	NN	O	16	PMOD	O
O	O	1997	1998	.	.	O	.	O	3	P	O
